HPLC determination of telmisartan in bulk and pharmaceutical formulations

Asian Journal of Chemistry

Volumn 18, Issue 2, 2006, Pages 775-782

  Rao, R Nageswara ^a   Sen, S ^a   Nagaraju, P ^a   Reddy, V Sumanth ^a   Krishnamurthy, P Radha ^a   Bhaskar, S Uday ^a  

^a Department of Pharmaceutics   (India)

Author keywords

Dosage forms; Reverse phase HPLC; Telmisartan

Indexed keywords

EID: 33645537972     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. L.S. Goodman and A. Gillman, The Pharmacological Basis of Therapeutics, MacMillan, New York (1980).
2. M.T. Xu, J.F. Song and Y.D. Liang, J. Pharm. Biomed. Anal., 34, 681 (2004).
3. S. Hillaert, W. van den Bossche, J. Pharm. Biomed. Anal., 31, 329 (2003).
4. -, J. Chromatogr, 979A, 323 (2002).
5. N. Torrealday, L. Gonzalez, R.M. Alonso, R.M. Jimenez and E.O. Lastra, J. Pharm. Biomed. Anal., 32, 847 (2003).
6. 19) + 4 Addendums (Aug. 2001).
7. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use: Harmonised Tripartite Guideline on Validation of Analytical Procedures: Methodology, Recommended for Adoption at Step 4 of the ICH Process on November 1996 by the ICH Steering Committee, IFPMA, Switzerland.